Based on published evidence indicating a therapeutic potentials in several tumor models we tested mAbs to CD137, CD40, CTLA-4, PD-1, TIM-3 and LAG-3 [34,35], as single agents and in combinations. Here, CTLA4 is linked to neoplasm.